Core Insights - Oklo Inc. (OKLO) is positioned at the intersection of advanced nuclear energy and the growth of artificial intelligence (AI), having secured a partnership with Meta Platforms (META) to develop a 1.2-gigawatt nuclear campus in Ohio [1][3] - Despite a previous surge in share price to a 52-week high of nearly $194, OKLO's stock has declined over 30% recently as investors reassess its valuation and execution risks [2][5] Company Developments - The agreement with META is a significant validation for OKLO, with pre-construction activities expected to start in 2026 and the first phase operational around 2030, with full delivery targeted by 2034 [3][4] - META's prepayment mechanism for the project provides upfront funding, which enhances capital visibility and reduces some financing uncertainties [3][12] Financial Performance - OKLO remains pre-revenue, reporting a loss of $0.20 per share in Q3 2025 and has missed earnings estimates in three of the last four quarters [10][12] - The company has a cash position of approximately $410 million but continues to experience negative free cash flow and relies on capital markets for funding [12] Market Position and Valuation - OKLO's shares are trading at over 8 times book value, significantly higher than its subindustry, despite having no operational reactors [6][8] - The stock's volatility reflects speculative positioning, with recent declines indicating that investor sentiment is more influenced by headlines than by financial progress [5][6] Industry Context - The nuclear energy sector is experiencing strong tailwinds, with projections indicating a potential 75% to 100% increase in U.S. electricity demand by 2050 due to AI [14] - Established operators like Constellation Energy (CEG) provide a more stable investment opportunity, generating billions in revenue and securing long-term power agreements with major tech companies [13][15] Technology and Future Prospects - OKLO is in the early stages of commercializing its sodium-cooled liquid-metal reactor technology, which presents engineering challenges and has not yet been proven at a commercial scale [16] - The company is also exploring additional initiatives, including a potential fuel facility in Tennessee and a military partnership in Alaska, which may stretch its capital and execution capabilities [16]

Market Overview - The Dow Jones has reached a record high of 50,000, but the focus should be on the S&P 500 and NASDAQ, where signs of weakness are emerging [1] - Concerns are rising regarding the impact of 'Agentic AI' on software companies operating on SaaS models, such as Salesforce and Wisetech, indicating potential self-cannibalization within the tech sector [2][3] AI and Technology - 'Agentic AI' combines ChatGPT with autonomous data collation capabilities, becoming a significant topic of investment interest [2] - The emergence of AI agents is perceived as a potential threat to software margins, although this fear may be exaggerated [5] Commodities - Gold prices have stabilized around US$5,000/oz, with no recent highs reported, suggesting a market reassessment of future economic conditions [6] - Rare earth element Neodymium prices are recovering, returning to late-COVID highs, indicating potential future growth in REE stocks [9][10][12] Inflation and Economic Indicators - The upcoming US inflation report is anticipated to influence market expectations for the March Federal Open Market Committee meeting [12][13] Uranium Market - Despite a drop in uranium prices, uranium stocks in the US have increased, highlighting a disconnect in market performance [14] - Major tech companies, including Meta, Google, and Microsoft, are planning to operate nuclear power plants to support data centers, generating market hype and potential tax benefits [15][16]

I am a Licensed Professional Engineer who works in the Nuclear Power industry. I use my professional working knowledge of the power/energy industries to aid in evaluating potential equities worthy of long-term investment. I invest in income producing equities and rental real estate properties for cash flow and long-term appreciation. My articles are to serve as a platform for presenting the underlying fundamentals and long-term potential of each equity/business.Analyst’s Disclosure: I/we have a beneficial l ...

Core Viewpoint - The article emphasizes the importance of evaluating potential equities in the Nuclear Power industry for long-term investment based on fundamental analysis and cash flow generation [1]. Group 1 - The author is a Licensed Professional Engineer with expertise in the Nuclear Power industry, utilizing professional knowledge to assess investment opportunities [1]. - The focus is on investing in income-producing equities and rental real estate properties to achieve cash flow and long-term appreciation [1]. - The articles aim to present the underlying fundamentals and long-term potential of each equity or business discussed [1].

The share price of Oklo Inc. (NYSE:OKLO) fell by 10.94% between February 3 and February 10, 2026, putting it among the Energy Stocks that Lost the Most This Week. OKLO Price Target Reduced by $15 dan-meyers-xXbQIrWH2_A-unsplash Backed by OpenAI’s Sam Altman, Oklo Inc. (NYSE:OKLO) develops advanced fission power plants to provide clean, reliable, and affordable energy at scale to customers in the United States. On February 4, Goldman Sachs lowered its price target on Oklo Inc. (NYSE:OKLO) from $106 to $ ...

Regarding our order book, new orders increased 18% in the fourth quarter, reflecting nearly 1.2 times book to bill were driven by continued solid demands within our naval defense and commercial nuclear markets. Next, I will highlight our full year 2025 results. We delivered another record financial performance with higher growth in revenue and operating income across all three segments reflecting the underlying demand and the momentum that continues to build across our portfolio. We delivered exceptional ma ...

Solstice Is Getting Ready for a Nuclear-Power Surge. The Stock Is Up. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Solstice Is Getting Ready for a Nuclear-Power Surge. The Stock Is Up.By [Al Root]ShareResize---ReprintsStorage containers ...

Shares of small modular (nuclear) power plant-builder NuScale Power (NYSE: SMR) stock tumbled 9.3% through 11:45 a.m. ET Wednesday. You can blame Wall Street analyst TD Cowen for that. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Image source: Getty Images. TD kicks NuScale to the curb This morning, you see, TD Cowen analyst Marc Bianchi downgraded NuScale stock from buy to hold, ...

Financial Data and Key Metrics Changes - In 2025, the company booked record orders totaling more than $1 billion, representing a 26% increase compared to 2024 [4][8] - Full year revenue totaled $925.4 million, up 7.5% versus 2024, with more than half of the growth being organic [22] - Adjusted EBITDA for the full year was $227.9 million, up 12% compared to 2024, with margins expanding by 90 basis points [22][26] - Adjusted EPS was $0.46, a 12% increase despite an approximately 50 million share increase in 2025 [23] Business Line Data and Key Metrics Changes - Nuclear power organic revenue grew more than 11% in 2025, while nuclear medicine organic revenue grew more than 13% [4] - The medical segment revenue declined 3.5% in Q4 2025, with full year medical segment revenue growing 3.7% [27] - Adjusted nuclear power orders grew 52% in 2025, supported by all three verticals: new utility-scale reactors, the installed base, and SMRs [20] Market Data and Key Metrics Changes - The nuclear power end market demonstrated the strongest growth, supported by $150 million from the large opportunity pipeline [8] - The defense and diversified end market saw a doubling of orders in Q4, primarily in the U.S. and with NATO [21] - The medical segment faced headwinds due to tough comps from the prior year, with nuclear medicine orders down only 6% in 2025 [9] Company Strategy and Development Direction - The company articulated a strategic priority to increase nuclear power exposure, acquiring Certrec and Paragon Energy Solutions to augment its North American nuclear power presence [5][11] - The company expects to leverage its strong international presence to take the capabilities of the acquired companies global [11] - The focus on AI and digital strategies is expected to enhance productivity and customer-facing applications, with significant investments being made in this area [61][66] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the nuclear power sector, citing a robust demand for solutions due to the aging installed base and modernization needs [6][7] - The company anticipates double-digit organic growth in nuclear power and nuclear medicine for 2026, supported by favorable macro conditions [4][15] - Management noted that the headwinds faced in 2025 were seen as demand deferrals rather than a secular change in the market [10] Other Important Information - Adjusted free cash flow totaled $131 million in 2025, approximately double 2024's performance, reflecting improved earnings and reduced net interest expense [29] - The company expects 2026 total revenue to grow between 22%-24%, with organic revenue growth guidance of 5%-7% [15][16] Q&A Session Summary Question: Can the large opportunity pipeline translate to double-digit growth in backlog for 2026? - Management noted that while large project timing is complex, they feel good about the dynamics driving growth in the nuclear power vertical [36][38] Question: What is the expectation for medical growth in 2026? - Management indicated that they expect a quick recovery in medical, particularly in Europe and China, and are optimistic about mid-single-digit growth [39][40] Question: How does the Paragon acquisition impact growth expectations? - Management highlighted that Paragon's strong customer intimacy and market coverage are expected to drive significant growth, with a projected 25% growth for Paragon in 2026 [68][70] Question: What is the expected contribution from large orders booked in 2025? - Management clarified that while there will be some contribution, the first year of larger contracts tends to be the lightest [78] Question: How material are SMRs to the growth story? - Management acknowledged that while SMRs are currently a small percentage of total revenue, they see significant growth potential and are actively engaging with key players in the market [81]

Financial Data and Key Metrics Changes - In 2025, the company booked record orders totaling more than $1 billion, representing a 26% increase compared to 2024 [4][8] - Full year revenue totaled $925.4 million, up 7.5% versus 2024, with more than half of the growth being organic [22] - Adjusted EBITDA for the year was $227.9 million, up 12% compared to 2024, with margins expanding by 90 basis points [22][26] - Adjusted EPS was $0.46, a 12% increase despite an increase in diluted shares due to convertible notes and equity raises [23] Business Line Data and Key Metrics Changes - Nuclear power organic revenue grew more than 11% in 2025, while nuclear medicine organic revenue grew more than 13% [4] - The medical segment revenue declined 3.5% in Q4 2025, with full year medical segment revenue growing 3.7% [27] - Adjusted nuclear power orders grew 52% in 2025, supported by all three verticals: new utility-scale reactors, the installed base, and SMRs [20] Market Data and Key Metrics Changes - The nuclear power end market demonstrated the strongest growth, with $150 million from the large opportunity pipeline [8] - The defense and diversified end market saw a doubling of orders in Q4, primarily in the U.S. and with NATO [21] - The medical segment faced headwinds due to tough comps from the prior year, with nuclear medicine orders down only 6% in 2025 [9] Company Strategy and Development Direction - The company articulated a strategic priority to increase nuclear power exposure, acquiring Sertrek and Paragon Energy Solutions to enhance its North American nuclear power presence [5][12] - The company expects to leverage its strong international presence to take the capabilities of the acquired companies global [11] - The focus on AI and digital strategies is expected to enhance customer-facing applications and internal productivity, with significant investments being made in this area [58][62] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the nuclear power sector, citing a robust demand for solutions due to the aging installed base and modernization needs [6][7] - The company anticipates double-digit organic growth in nuclear power and nuclear medicine for 2026, supported by favorable macro conditions [4][15] - Management acknowledged headwinds in the medical segment but remains optimistic about margin expansion and operational improvements [27][29] Other Important Information - Adjusted free cash flow totaled $131 million in 2025, approximately double that of 2024, reflecting improved earnings and reduced net interest expense [29] - The company expects 2026 total revenue growth between 22%-24%, with organic revenue growth guidance of 5%-7% [15][16] Q&A Session Summary Question: Can the large opportunity pipeline translate to double-digit growth in backlog for 2026? - Management noted that while large project timing is complex, they feel good about the underlying dynamics driving growth in the nuclear power vertical [34][36] Question: What is the expectation for medical segment growth in 2026? - Management indicated that they expect mid-single-digit growth in the medical segment, with a recovery anticipated in Europe and China [37][38] Question: How does the Paragon acquisition impact Q1 guidance? - Management stated that Q1 will be the lightest quarter for both Mirion and Paragon, with expected margin contraction due to the dilutive nature of the Paragon acquisition [44][46] Question: What is the expected contribution from SMRs to growth? - Management indicated that while SMRs are currently a small percentage of total revenue, they see significant growth potential and are actively engaging with key SMR developers [75][77] Question: Can you provide insights on the Sertrek acquisition? - Management highlighted that Sertrek broadens the nuclear power portfolio and enhances access to the SMR market, contributing positively to overall growth [79]